Answers are grounded in this paper and cite their sources.
Immunoglobulin A nephropathy is a rare renal condition, and despite a large number of cases progressing to end-stage kidney disease, the mechanisms behind the illness are not fully understood. Haresh Selvaskandan, Melanie Dillon and Jonathan Barratt discuss how having access to an international rare disease registry with data on this disease can help improve kidney care around the world.
No takes yet. Share an insight, caveat, or question.
Selvaskandan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: